Clariane (FR:CLARI)
:CLARI
Want to see FR:CLARI full AI Analyst Report?
CLARI Stock Chart & Stats
€3.93
€0.01(0.72%)
At close: 4:00 PM EST
€3.93
€0.01(0.72%)
Day’s Range― - ―
52-Week Range€3.27 - €5.51
Previous CloseN/A
Volume244.36K
Average Volume (3M)711.69K
Market Cap
€1.45B
Enterprise Value€8.46B
Total Cash (Recent Filing)€821.56M
Total Debt (Recent Filing)€7.81B
Price to Earnings (P/E)899.1
Beta1.39
Next Earnings
Jul 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding357,540,860
10 Day Avg. Volume394,627
30 Day Avg. Volume711,689
Financial Highlights & Ratios
PEG Ratio-8.51
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio2.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€4.70Price Target Upside19.59% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.41
Revenue Forecast (FY)€5.40B
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistent positive operating and free cash flow over multiple years provides durable internal funding for operations, maintenance capex and selective investments. That recurring cash generation enhances resilience to cyclical demand and supports strategic initiatives without immediate reliance on capital markets.
Revenue Growth MomentumSustained, accelerating revenue growth reflects expanding utilization across facilities and service lines and benefits from structural demographic demand. Durable top-line expansion supports scale economics, better utilization of fixed costs and positions the company to capture incremental market share across European care services.
Stable Operating MarginsRelatively steady EBITDA and EBIT margins indicate the core care-services model generates consistent operating earnings despite volume or reimbursement variability. Stable operating profitability underpins cash flow reliability and provides a buffer for reinvestment and margin protection amid pricing or input cost shifts.
Bears Say
High And Rising LeverageElevated and increasing leverage materially raises financing risk and sensitivity to interest rates, limiting financial flexibility. High debt amplifies the impact of earnings volatility, constrains ability to fund growth internally, and increases refinancing and covenant exposure over a multi-month horizon.
Weak And Volatile Net IncomeDespite stable operating margins, bottom-line volatility from financing and non-operating items undermines capital accumulation and returns. Near-zero net profitability limits retained earnings, reduces buffer against shocks and hinders ability to deleverage or fund investments from earnings alone.
Revenue & Cost Sensitivity To Reimbursement And LaborBusiness model dependency on public reimbursement frameworks and labor supply makes revenues and margins structurally exposed to policy shifts and wage inflation. Regulatory or reimbursement changes and persistent staffing cost pressures could compress margins and occupancy economics over the medium term.
CLARI FAQ
What was Clariane’s price range in the past 12 months?
Clariane lowest stock price was €3.27 and its highest was €5.50 in the past 12 months.
What is Clariane’s market cap?
Clariane’s market cap is €1.45B.
When is Clariane’s upcoming earnings report date?
Clariane’s upcoming earnings report date is Jul 29, 2026 which is in 41 days.
How were Clariane’s earnings last quarter?
Clariane released its earnings results on Feb 26, 2026. The company reported €0.169 earnings per share for the quarter, beating the consensus estimate of N/A by €0.169.
Is Clariane overvalued?
According to Wall Street analysts Clariane’s price is currently Undervalued.
Does Clariane pay dividends?
Clariane pays a Annually dividend of €0.25 which represents an annual dividend yield of N/A. See more information on Clariane dividends here
What is Clariane’s EPS estimate?
Clariane’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clariane have?
Clariane has 357,540,860 shares outstanding.
What happened to Clariane’s price movement after its last earnings report?
Clariane reported an EPS of €0.169 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.285%.
Which hedge fund is a major shareholder of Clariane?
Currently, no hedge funds are holding shares in FR:CLARI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Clariane
Clariane SE, established in Paris, France, in 2001 and known as Korian until its rebranding in June 2023, specializes in delivering comprehensive medical and non-medical care and support. The company serves senior citizens and individuals facing either temporary or chronic health challenges through a diverse range of provisions. These offerings encompass residential facilities like long-term nursing homes, specialized medical clinics, and senior living communities, including assisted living and co-housing arrangements. Furthermore, Clariane extends its services to include in-home care, various support programs, and hospitalization. Its operational footprint spans multiple European nations, including France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
CLARI Stock 12 Month Forecast
Average Price Target
€4.70
▲(19.59% Upside)
Technical Analysis
Options Prices
Currently, No data available
---